| pubmed-article:11346878 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11346878 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11346878 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:11346878 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:11346878 | lifeskim:mentions | umls-concept:C0237428 | lld:lifeskim |
| pubmed-article:11346878 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:11346878 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:11346878 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:11346878 | pubmed:dateCreated | 2001-5-10 | lld:pubmed |
| pubmed-article:11346878 | pubmed:abstractText | Previous research has found that cancer patients often overestimate the likelihood that they will achieve a positive response in Phase I trials. However, maintaining optimistic expectations may help patients cope with a poor prognosis and uncertain outcome. The authors prospectively examined the association between treatment-specific optimism and mental health among patients participating in a Phase I/b trial. | lld:pubmed |
| pubmed-article:11346878 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11346878 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11346878 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11346878 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11346878 | pubmed:month | May | lld:pubmed |
| pubmed-article:11346878 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:11346878 | pubmed:author | pubmed-author:CohenLL | lld:pubmed |
| pubmed-article:11346878 | pubmed:author | pubmed-author:AmatoR JRJ | lld:pubmed |
| pubmed-article:11346878 | pubmed:author | pubmed-author:de MoorCC | lld:pubmed |
| pubmed-article:11346878 | pubmed:copyrightInfo | Copyright 2001 American Cancer Society. | lld:pubmed |
| pubmed-article:11346878 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11346878 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:11346878 | pubmed:volume | 91 | lld:pubmed |
| pubmed-article:11346878 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11346878 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11346878 | pubmed:pagination | 1949-55 | lld:pubmed |
| pubmed-article:11346878 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:meshHeading | pubmed-meshheading:11346878... | lld:pubmed |
| pubmed-article:11346878 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11346878 | pubmed:articleTitle | The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a Phase I cancer clinical trial. | lld:pubmed |
| pubmed-article:11346878 | pubmed:affiliation | Department of Behavioral Science, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. lcohen@notes.mdacc.tmc.edu | lld:pubmed |
| pubmed-article:11346878 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11346878 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11346878 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11346878 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11346878 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11346878 | lld:pubmed |
